Skip to main content
SpringerLink
Log in

Transgenic animals as tools in drug development

  • Future Trends in the Therapy of Inflammatory Disease
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

A transgenic animal can be defined as an organism that has undergone a stable modification of genotype as a result of genetic manipulation. Such animals are being increasingly employed as research and development tools by both academic and commercial institutions. The primary methods by which transgenic animals can be generated will be described. The relative merits of the approaches will be illustrated, as will their potential use in the discovery and development of novel therapeutic entities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. R. Jaenisch,Transgenic animals. Science240, 1468–1474 (1988).

    PubMed  Google Scholar 

  2. A. D. Miller,Human gene therapy comes of age. Nature357, 455–460 (1992).

    PubMed  Google Scholar 

  3. N. Sarvetnick, D. Liggitt, S. L. Pitts, S. E. Hansen and T. A. Stewart,Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-γ. Cell52, 773–782 (1988).

    PubMed  Google Scholar 

  4. R. L. Tepper, D. A. Levinson, B. Z. Stranger, J. Campos Torres, A. K. Abbas and P. Leder,IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell62, 456–467 (1990).

    Google Scholar 

  5. R. E. Hammer, S. D. Maika, J. A. Richardson, J.-P. Tang and J. D. Taurog, Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and humanβ 2 m: An animal model of HLA-B27-associated human disorders. Cell63, 1099–1112 (1990).

    PubMed  Google Scholar 

  6. P. S. Jat, M. D. Noble, P. Ataliotis, Y. Tanaka, N. Yannoutsos, L. Larsen and S. Kiousis,Direct derivation of conditionally immortal cell lines from an H-2K b -tsA58 transgenic mouse. Proc. Natl. Acad. Sci.88, 5096–5100 (1991).

    PubMed  Google Scholar 

  7. J. A. Gossen, W. J. F. de Leeuw, C. H. T. Tan, E. C. Zwarthoff, F. Berends, P. H. M. Lohman, D. L. Knook and J. Vug,Efficient rescue of integrated shuttle vectors from transgenic mice: A model for studying mutations in vivo. Proc. Natl. Acad. Sci.86, 7971–7975 (1989).

    PubMed  Google Scholar 

  8. S. W. Kholer, G. S. Provest, A. Fieck, P. L. Kretz, W. O. Bullock, J. A. Sorge, D. L. Putman and J. M. Short,Spectra of spontaneous and mutagen-induced mutations in the IacI gene in transgenic mice. Proc. Natl. Acad. Sci.88, 7958–7962 (1991).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Glaxo Group Research Ltd., UB6 0HE, Greenford, Middlesex, UK

    S. Harris, N. K. Davis, M. I. Jowett, E. S. Rees & S. Topps

Authors
  1. S. Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. K. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. I. Jowett
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. S. Rees
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Topps
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harris, S., Davis, N.K., Jowett, M.I. et al. Transgenic animals as tools in drug development. Agents and Actions 38 (Suppl 2), C57–C58 (1993). https://doi.org/10.1007/BF01991136

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01991136

Keywords

Search

Navigation